WeightWatchers is going all-in on trendy new anti-obesity drugs. The gamble might save the company—if it doesn’t kill it first. By Emma Court and Ellen Huet
Listen to the Story
451 clip(s)
A Billionaire Gets a Gold Mine in America’s Critical Minerals Scramble
India’s Digital Dream, Hacked
Can Target Be Cool Again, and Would That Be Enough?